The allele Thr300Ala in ATG16L1 is strongly correlated with increased overall survival in human CRC (57), which may explain why ATG16L1 decreased rather than increased in the CRC + Fn + Cys group. This evidence concerns the gene FN1 and colorectal carcinoma.